Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

U.S. National Cancer Institute perspective on precision oncology

Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA

U.S. National Cancer Institute perspective on precision oncology ( Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA )

Early development in oncology: Are the MTD and monotherapy efficacy still the...

Dr Giorgio Massimini - Merck KGaA, Germany

Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives? ( Dr Giorgio Massimini - Merck KGaA, Germany )

Lessons from long-term survey of stage I NSCLC

Prof Harvey Pass - New York University Langone Medical Center, New York, USA

Lessons from long-term survey of stage I NSCLC ( Prof Harvey Pass - New York University Langone Medical Center, New York, USA )

Precision CAR T cell therapeutics

Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA

Precision CAR T cell therapeutics ( Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA )

Implementing precision medicine in oncology: The IMPACT trials

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

Implementing precision medicine in oncology: The IMPACT trials ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )

Treating CLL with obinutuzumab

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany

Treating CLL with obinutuzumab ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )

First in-human trial of AMV564 for AML

Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA

First in-human trial of AMV564 for AML ( Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA )

SETBP1 induces transcription of developmental genes

Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy

SETBP1 induces transcription of developmental genes ( Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy )

Combination therapy for CLL in the CAPTIVATE trial

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

Combination therapy for CLL in the CAPTIVATE trial ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )

More from ecancer